Related Experiment Video
Updated: Aug 4, 2026
09:27
New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
Published on: May 30, 2013
Pediatric HIV disease: new developments in treatment and prevention
1University of Washington, Seattle, USA.
AIDS Clinical Review
|January 1, 1997
Summary
Preventing mother-to-child HIV transmission is possible with early identification and treatment. New antiretroviral therapies offer hope for slowing disease progression in infected children.
Area of Science:
- Pediatrics
- Infectious Diseases
- Virology
Background:
- Increasing incidence of Human Immunodeficiency Virus type 1 (HIV-1) infection in children.
- Established methods for preventing mother-to-child transmission (PMTCT) of HIV-1.
- Advancements in understanding HIV-1 viral dynamics.
Purpose of the Study:
- To highlight the potential for reducing pediatric HIV-1 incidence.
- To discuss the role of antiretroviral agents and obstetrical management in PMTCT.
- To explore improved treatment strategies for HIV-1-infected children.
Main Methods:
- Prospective identification of HIV-1-infected pregnant women.
- Application of antiretroviral agents for PMTCT.
- Implementation of improved obstetrical management protocols.
- Analysis of viral dynamics in pediatric HIV-1 infection.
Main Results:
- Optimism for diminishing the incidence of HIV-1 infection in children.
- Potential for slowing disease progression in HIV-1-infected children.
- Hope for enhanced treatment strategies due to potent antiretroviral agents.
Conclusions:
- Early identification and intervention are key to reducing pediatric HIV-1.
- Antiretroviral therapy and optimized obstetrical care are crucial for PMTCT.
- Ongoing research into viral dynamics and new therapies promises better outcomes for HIV-1-infected children.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...